Market Overview:
The global peanut allergy therapeutics market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of peanut allergies, rising awareness about peanut allergy therapies, and technological advancements in the field of peanut allergy therapeutics. The global peanut allergy therapeutics market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into ANB-020, ANN-004, AR-101, ASP-0892 DBV-712 Others. On the basis of application,the market is segmented into clinic hospital home care.
Product Definition:
Peanut allergy therapeutics are treatments used to manage peanut allergies. Peanut allergies are a type of food allergy that occurs when the body mistakenly identifies peanuts as harmful invaders. The body's immune system produces antibodies to fight the peanut proteins, which can lead to a range of symptoms, from mild skin reactions to life-threatening anaphylactic shock. There is currently no cure for peanut allergies, but there are several therapies that can help reduce or prevent allergic reactions. These include allergen immunotherapy (desensitization), medications such as antihistamines and epinephrine injections, and dietary changes.
ANB-020:
ANB-020 is a novel oral immunotherapy drug developed by Allergy Therapeutics for the treatment of peanut allergy. It is currently in phase II clinical trials and has shown encouraging results. The company plans to apply for FDA approval by 2019, which if approved would be the first oral immunotherapy drug for peanut allergy treatment.
The market size of peanut allergic therapeutics was valued at USD 473 million in 2016.
ANN-004:
It is an investigational anti-inflammatory drug developed by Annova Therapeutics for peanut allergy. The company has initiated a Phase II trial of the drug in 2017 and completed enrollment in 2018. It plans to initiate a Phase III trial during 2019, which would result in the launch of the product by 2020.
The Food Allergy Research.
Application Insights:
Based on application, the global market is segmented into clinic, hospital and home care. Clinic held the largest share of over 70% in 2017 owing to increasing prevalence of peanut allergy among children. According to a study published by NCBI in 2018, around 1 out of 5 children have been found to be allergic to peanuts. Furthermore, rising number of clinics offering allergen-free products will drive the segment growth during forecast period.
Hospital is expected register fastest CAGR over the forecast period due largely Peanut Corporation Of America (PCOA) initiatives such as providing training for medical professionals about peanut allergy and conducting research studies about its product portfolio with various hospitals across U.S.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of peanut-allergic patients and rising awareness about peanut allergy treatment are some factors contributing to its largest share. In addition, the availability of reimbursement coverage for emergency room and hospital visits associated with food allergies is also expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to an increase in healthcare expenditure, growing penetration of private insurance companies, and rising prevalence of nut allergies across countries such as India and China. Furthermore, increasing medical tourism due to affordability offered by this region will also boost demand for ANA testing services in this region over the next eight years.
Growth Factors:
- Increasing prevalence of peanut allergy: The global prevalence of peanut allergy is increasing at a significant rate. This is primarily due to the changing lifestyle and dietary habits. According to a study by the Journal of Allergy and Clinical Immunology, the number of people with peanut allergies has tripled in Europe and North America in the past decade. This is expected to drive the growth of Peanut Allergy Therapeutics market in these regions.
- Growing awareness about peanut allergies: There is growing awareness among people about peanut allergies, which is driving them to seek treatment for it. This will create opportunities for Peanut Allergy Therapeutics market players to capitalize on this trend by introducing new therapies and treatments for this condition.
- Technological advancements: The field of Peanut Allergy Therapeutics is witnessing rapid advancements with respect to technology-based treatments such as immunotherapy and gene therapy being developed currently or in clinical trials stages that are likely show better efficacy outcomes than traditional therapies available currently .This will spur growth prospects for Peanut Allergy Therapeutics market players over the forecast period .
Scope Of The Report
Report Attributes
Report Details
Report Title
Peanut Allergy Therapeutics Market Research Report
By Type
ANB-020, ANN-004, AR-101, ASP-0892, DBV-712, Others
By Application
Clinic, Hospital, Home Care
By Companies
Adverum Biotechnologies Inc, Aimmune Therapeutics Inc, Alfacyte Ltd, Allergy Therapeutics Plc, AnaptysBio Inc, ASIT Biotech SA, Astellas Pharma Inc, BioLingus AG, DBV Technologies SA, HAL Allergy BV, Intrommune Therapeutics, Sanofi, Selecta Biosciences Inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
179
Number of Tables & Figures
126
Customization Available
Yes, the report can be customized as per your need.
Global Peanut Allergy Therapeutics Market Report Segments:
The global Peanut Allergy Therapeutics market is segmented on the basis of:
Types
ANB-020, ANN-004, AR-101, ASP-0892, DBV-712, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinic, Hospital, Home Care
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Adverum Biotechnologies Inc
- Aimmune Therapeutics Inc
- Alfacyte Ltd
- Allergy Therapeutics Plc
- AnaptysBio Inc
- ASIT Biotech SA
- Astellas Pharma Inc
- BioLingus AG
- DBV Technologies SA
- HAL Allergy BV
- Intrommune Therapeutics
- Sanofi
- Selecta Biosciences Inc
Highlights of The Peanut Allergy Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- ANB-020
- ANN-004
- AR-101
- ASP-0892
- DBV-712
- Others
- By Application:
- Clinic
- Hospital
- Home Care
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Peanut Allergy Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Peanut allergy therapeutics are medications that help people with peanut allergies avoid exposure to peanuts. These medications can be taken by mouth or injected into the skin.
Some of the key players operating in the peanut allergy therapeutics market are Adverum Biotechnologies Inc, Aimmune Therapeutics Inc, Alfacyte Ltd, Allergy Therapeutics Plc, AnaptysBio Inc, ASIT Biotech SA, Astellas Pharma Inc, BioLingus AG, DBV Technologies SA, HAL Allergy BV, Intrommune Therapeutics, Sanofi, Selecta Biosciences Inc.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Peanut Allergy Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Peanut Allergy Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Peanut Allergy Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Peanut Allergy Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Peanut Allergy Therapeutics Market Size & Forecast, 2020-2028
4.5.1 Peanut Allergy Therapeutics Market Size and Y-o-Y Growth
4.5.2 Peanut Allergy Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 ANB-020
5.2.2 ANN-004
5.2.3 AR-101
5.2.4 ASP-0892
5.2.5 DBV-712
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Clinic
6.2.2 Hospital
6.2.3 Home Care
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Peanut Allergy Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Peanut Allergy Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 ANB-020
9.6.2 ANN-004
9.6.3 AR-101
9.6.4 ASP-0892
9.6.5 DBV-712
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Clinic
9.10.2 Hospital
9.10.3 Home Care
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 ANB-020
10.6.2 ANN-004
10.6.3 AR-101
10.6.4 ASP-0892
10.6.5 DBV-712
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Clinic
10.10.2 Hospital
10.10.3 Home Care
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 ANB-020
11.6.2 ANN-004
11.6.3 AR-101
11.6.4 ASP-0892
11.6.5 DBV-712
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Clinic
11.10.2 Hospital
11.10.3 Home Care
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 ANB-020
12.6.2 ANN-004
12.6.3 AR-101
12.6.4 ASP-0892
12.6.5 DBV-712
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Clinic
12.10.2 Hospital
12.10.3 Home Care
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 ANB-020
13.6.2 ANN-004
13.6.3 AR-101
13.6.4 ASP-0892
13.6.5 DBV-712
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Clinic
13.10.2 Hospital
13.10.3 Home Care
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Peanut Allergy Therapeutics Market: Competitive Dashboard
14.2 Global Peanut Allergy Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Adverum Biotechnologies Inc
14.3.2 Aimmune Therapeutics Inc
14.3.3 Alfacyte Ltd
14.3.4 Allergy Therapeutics Plc
14.3.5 AnaptysBio Inc
14.3.6 ASIT Biotech SA
14.3.7 Astellas Pharma Inc
14.3.8 BioLingus AG
14.3.9 DBV Technologies SA
14.3.10 HAL Allergy BV
14.3.11 Intrommune Therapeutics
14.3.12 Sanofi
14.3.13 Selecta Biosciences Inc
